Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,438 | 19,473 | 69,870 | 90,456 | 6,448 |
| Marketable Securities | 16,288 | 43,260 | N/A | N/A | N/A |
| Receivables | 18,657 | 33,936 | 23,217 | 8,006 | 5,345 |
| Inventories | 43,456 | 34,904 | 28,345 | 11,602 | 10,972 |
| TOTAL | $120,604 | $138,452 | $126,088 | $114,712 | $24,113 |
| Non-Current Assets | |||||
| PPE Net | 21,077 | 23,638 | 17,657 | 10,120 | 5,572 |
| Investments And Advances | 5,617 | 6,401 | 4,372 | 5,872 | 2,500 |
| Intangibles | 245,890 | 256,829 | 376,890 | 89,498 | 55,619 |
| Other Non-Current Assets | 19,526 | 24,909 | 29,279 | 14,627 | 5,012 |
| TOTAL | $292,110 | $311,777 | $428,198 | $120,117 | $68,703 |
| Total Assets | $412,714 | $450,229 | $554,286 | $234,829 | $92,816 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,833 | 1,814 | 862 | 614 | N/A |
| Accounts payable and accrued liabilities | 6,940 | 15,367 | 14,945 | 3,672 | 3,119 |
| Accrued Expenses | 11,932 | 9,782 | 6,870 | 4,543 | 3,369 |
| Other current liabilities | 13,300 | 14,601 | 17,116 | 5,629 | 377 |
| TOTAL | $42,178 | $44,582 | $42,700 | $15,573 | $7,669 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,311 | 23,793 | 6,353 | 655 | N/A |
| aiOther Non-Current Liabilities | 13,205 | 17,290 | 21,408 | 13,343 | 41,693 |
| TOTAL | $32,873 | $41,459 | $33,539 | $14,010 | $41,693 |
| Total Liabilities | $75,051 | $86,041 | $76,239 | $29,583 | $49,362 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,300 | 43,212 | 42,095 | 33,401 | 24,000 |
| Common Shares | 45 | 43 | 42 | 33 | 21 |
| Retained earnings | -313,342 | -246,915 | -107,110 | -97,385 | -100,052 |
| Other shareholders' equity | -345 | -679 | -282 | 0 | 0 |
| TOTAL | $337,663 | $364,188 | $478,047 | $205,246 | $43,454 |
| Total Liabilities And Equity | $412,714 | $450,229 | $554,286 | $234,829 | $92,816 |